{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:20:15Z","timestamp":1791249615502,"version":"4.1.0"},"reference-count":47,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2015,3,5]],"date-time":"2015-03-05T00:00:00Z","timestamp":1425513600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0119476","type":"journal-article","created":{"date-parts":[[2015,3,5]],"date-time":"2015-03-05T19:07:49Z","timestamp":1425582469000},"page":"e0119476","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":13,"title":["p53 Status Correlates with the Risk of Recurrence in Non-Muscle Invasive Bladder Cancers Treated with Bacillus Calmette\u2013Gu\u00e9rin: A Meta-Analysis"],"prefix":"10.1371","volume":"10","author":[{"given":"Xiaofeng","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,3,5]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00345-009-0383-3","article-title":"The present and future burden of urinary bladder cancer in the world","volume":"27","author":"M Ploeg","year":"2009","journal-title":"World J Urol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"A Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"S188","DOI":"10.5489\/cuaj.1194","article-title":"The optimal management of T1 high-grade bladder cancer","volume":"3","author":"KG Nepple","year":"2009","journal-title":"Can Urol Assoc J"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4103\/0974-7796.84954","article-title":"Long-term prognostic value of the combination of EORTC risk group calculator and molecular markers in non-muscle-invasive bladder cancer patients treated with intravesical Bacille Calmette-Guerin","volume":"3","author":"SS Alkhateeb","year":"2011","journal-title":"Urol Ann"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"567","DOI":"10.2298\/VSP1107567D","article-title":"Expression of regulatory proteins and proliferative activity in relation to phenotypic characteristics of upper urothelial carcinoma","volume":"68","author":"Z Dolicanin","year":"2011","journal-title":"Vojnosanit Pregl"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"4159","DOI":"10.1007\/s11033-010-0536-x","article-title":"Expression of genes related to apoptosis, cell cycle and signaling pathways are independent of TP53 status in urinary bladder cancer cells","volume":"38","author":"GN da Silva","year":"2011","journal-title":"Mol Biol Rep"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.urolonc.2011.06.004","article-title":"Do molecular biomarkers have prognostic value in primary T1G3 bladder cancer treated with bacillus Calmette-Guerin intravesical therapy?","volume":"31","author":"J Park","year":"2013","journal-title":"Urol Oncol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1111\/j.1464-410X.2012.10996.x","article-title":"Prognostic value of molecular markers, sub-stage and European Organisation for the Research and Treatment of Cancer risk scores in primary T1 bladder cancer","volume":"110","author":"BW van Rhijn","year":"2012","journal-title":"BJU Int"},{"key":"ref9","first-page":"4201","article-title":"Altered p53 and pRb expression is predictive of response to BCG treatment in T1G3 bladder cancer","volume":"29","author":"L Cormio","year":"2009","journal-title":"Anticancer Res"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1002\/cncr.22503","article-title":"Predictive value of p53 and pRb expression in superficial bladder cancer patients treated with BCG and interferon-alpha","volume":"109","author":"K Esuvaranathan","year":"2007","journal-title":"Cancer"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0090-4295(01)01551-5","article-title":"Prognostic value of p53 overexpression in T1G3 bladder tumors treated with bacillus Calmette-Guerin therapy","volume":"59","author":"M Peyromaure","year":"2002","journal-title":"Urology"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.eururo.2003.11.018","article-title":"Pretreatment p53 nuclear overexpression as a prognostic marker in superficial bladder cancer treated with Bacillus Calmette-Guerin (BCG)","volume":"45","author":"F Saint","year":"2004","journal-title":"Eur Urol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1159\/000327214","article-title":"A six-week course of bacillus Calmette-Guerin prophylaxis is insufficient to prevent tumor recurrence in nonmuscle invasive bladder cancer with strong-positive expression of p53","volume":"79","author":"JJ Oh","year":"2010","journal-title":"Oncology"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1442-2042.1997.tb00307.x","article-title":"Prognostic markers of intravesical bacillus Calmette-Guerin therapy for multiple, high-grade, stage T1 bladder cancers","volume":"4","author":"E Lee","year":"1997","journal-title":"Int J Urol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1159\/000343431","article-title":"Prognostic factors including Ki-67 and p53 in Bacillus Calmette-Guerin-treated non-muscle-invasive bladder cancer: a prospective study","volume":"90","author":"M Oderda","year":"2013","journal-title":"Urol Int"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.eururo.2003.11.011","article-title":"Prognostic factors in stage T1 grade 3 bladder cancer survival: the role of G1-S modulators (p53, p21Waf1, p27kip1, Cyclin D1, and Cyclin D3) and proliferation index (ki67-MIB1)","volume":"45","author":"A Lopez-Beltran","year":"2004","journal-title":"Eur Urol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1200\/JCO.1996.14.10.2646","article-title":"Overexpression of p53 protein in a high-risk population of patients with superficial bladder cancer before and after bacillus Calmette-Guerin therapy: correlation to clinical outcome","volume":"14","author":"L Lacombe","year":"1996","journal-title":"J Clin Oncol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nrn3475","article-title":"Power failure: why small sample size undermines the reliability of neuroscience","volume":"14","author":"KS Button","year":"2013","journal-title":"Nat Rev Neurosci"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.1200\/JCO.2011.35.7566","article-title":"Association between vitamin D and risk of colorectal cancer: a systematic review of prospective studies","volume":"29","author":"Y Ma","year":"2011","journal-title":"J Clin Oncol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"A Liberati","year":"2009","journal-title":"PLoS Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","article-title":"Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints","volume":"17","author":"MK Parmar","year":"1998","journal-title":"Stat Med"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"R DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1056\/NEJM199207233270406","article-title":"Cumulative meta-analysis of therapeutic trials for myocardial infarction","volume":"327","author":"J Lau","year":"1992","journal-title":"N Engl J Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"JP Higgins","year":"2002","journal-title":"Stat Med"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/aje\/kwn340","article-title":"More than numbers: the power of graphs in meta-analysis","volume":"169","author":"L Bax","year":"2009","journal-title":"Am J Epidemiol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/annonc\/mds508","article-title":"Alcohol drinking and all cancer mortality: a meta-analysis","volume":"24","author":"M Jin","year":"2013","journal-title":"Ann Oncol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1007\/s00394-014-0667-2","article-title":"Dietary carrot consumption and the risk of prostate cancer","volume":"53","author":"X Xu","year":"2014","journal-title":"Eur J Nutr"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"CB Begg","year":"1994","journal-title":"Biometrics"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"M Egger","year":"1997","journal-title":"BMJ"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","article-title":"Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis","volume":"56","author":"S Duval","year":"2000","journal-title":"Biometrics"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.eururo.2009.06.028","article-title":"Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy","volume":"56","author":"BW van Rhijn","year":"2009","journal-title":"Eur Urol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/CCO.0b013e32835eb583","article-title":"Management of superficial and muscle-invasive urothelial cancers of the bladder","volume":"25","author":"MJ Resnick","year":"2013","journal-title":"Curr Opin Oncol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.eururo.2012.08.061","article-title":"ICUD-EAU International Consultation on Bladder Cancer 2012: Non-muscle-invasive urothelial carcinoma of the bladder","volume":"63","author":"M Burger","year":"2013","journal-title":"Eur Urol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.eururo.2013.06.003","article-title":"EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013","volume":"64","author":"M Babjuk","year":"2013","journal-title":"Eur Urol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1038\/bjc.2013.372","article-title":"Accuracy of the EORTC risk tables and of the CUETO scoring model to predict outcomes in non-muscle-invasive urothelial carcinoma of the bladder","volume":"109","author":"E Xylinas","year":"2013","journal-title":"Br J Cancer"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.eururo.2011.06.001","article-title":"How well can you actually predict which non-muscle-invasive bladder cancer patients will progress?","volume":"60","author":"RJ Sylvester","year":"2011","journal-title":"Eur Urol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"9030","DOI":"10.1038\/sj.onc.1207116","article-title":"Control of apoptosis by p53","volume":"22","author":"JS Fridman","year":"2003","journal-title":"Oncogene"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1083\/jcb.201009059","article-title":"p53 and its mutants in tumor cell migration and invasion","volume":"192","author":"PA Muller","year":"2011","journal-title":"J Cell Biol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1159\/000020295","article-title":"Evaluation of P53 protein overexpression, Ki67 proliferative activity and mitotic index as markers of tumour recurrence in superficial transitional cell carcinoma of the bladder","volume":"38","author":"P Gontero","year":"2000","journal-title":"Eur Urol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0046-8177(98)90225-8","article-title":"The prevalence of bcl-2, p53, and Ki-67 immunoreactivity in transitional cell bladder carcinomas and their clinicopathologic correlates","volume":"29","author":"L Nakopoulou","year":"1998","journal-title":"Hum Pathol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/S0022-5347(05)68347-4","article-title":"Immunohistochemical detection of p53 protein overexpression versus gene sequencing in urinary bladder carcinomas","volume":"162","author":"S Bernardini","year":"1999","journal-title":"J Urol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1007\/s11033-012-2319-z","article-title":"Quantitative assessment of the association between TP53 Arg72Pro polymorphism and bladder cancer risk","volume":"40","author":"ZH Liu","year":"2013","journal-title":"Mol Biol Rep"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.gene.2012.09.085","article-title":"Association of p53 Arg72Pro polymorphism with bladder cancer: a meta-analysis","volume":"512","author":"Z Yang","year":"2013","journal-title":"Gene"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.7314\/APJCP.2012.13.5.2349","article-title":"P53 Arg72Pro polymorphism and bladder cancer risk\u2014meta-analysis evidence for a link in Asians but not Caucasians","volume":"13","author":"T Xu","year":"2012","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"765 e761","DOI":"10.1016\/j.urology.2010.04.044","article-title":"Meta-analysis of association between TP53 Arg72Pro polymorphism and bladder cancer risk","volume":"76","author":"DK Jiang","year":"2010","journal-title":"Urology"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.4238\/vol9-3gmr882","article-title":"Meta-analysis of epidemiological studies of association of P53 codon 72 polymorphism with bladder cancer","volume":"9","author":"DB Li","year":"2010","journal-title":"Genet Mol Res"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S1470-2045(05)70315-6","article-title":"P53 as a prognostic marker for bladder cancer: a meta-analysis and review","volume":"6","author":"N Malats","year":"2005","journal-title":"Lancet Oncol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0119476","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,30]],"date-time":"2020-08-30T15:14:06Z","timestamp":1598800446000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0119476"}},"subtitle":[],"editor":[{"given":"Masaharu","family":"Seno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,3,5]]},"references-count":47,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2015,3,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0119476","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,5]]}}}